106 related articles for article (PubMed ID: 11295614)
1. Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials.
Ali IU; Senger DR; Smith LE
Urology; 2001 Apr; 57(4 Suppl 1):143-7. PubMed ID: 11295614
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
Mazzucchelli R; Montironi R; Santinelli A; Lucarini G; Pugnaloni A; Biagini G
Prostate; 2000 Sep; 45(1):72-9. PubMed ID: 10960845
[TBL] [Abstract][Full Text] [Related]
3. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and prostate cancer: identification of a molecular progression switch.
Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
[TBL] [Abstract][Full Text] [Related]
5. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of angiogenic apelin/apelin receptor axis in normal prostate, high grade prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Soylu H; Unal B; Aksu K; Avci S; Caylan AE; Ustunel I I
Malays J Pathol; 2022 Dec; 44(3):461-467. PubMed ID: 36591713
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue.
Köllermann J; Helpap B
Am J Clin Pathol; 2001 Jul; 116(1):115-21. PubMed ID: 11447740
[TBL] [Abstract][Full Text] [Related]
9. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
10. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.
Freeman KW; Welm BE; Gangula RD; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
Cancer Res; 2003 Dec; 63(23):8256-63. PubMed ID: 14678983
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and prostate cancer tumor growth.
Nicholson B; Theodorescu D
J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
[TBL] [Abstract][Full Text] [Related]
12. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma.
Ozawa MG; Yao VJ; Chanthery YH; Troncoso P; Uemura A; Varner AS; Kasman IM; Pasqualini R; Arap W; McDonald DM
Cancer; 2005 Nov; 104(10):2104-15. PubMed ID: 16208706
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of angiogenesis markers.
Shih SC; Robinson GS; Perruzzi CA; Calvo A; Desai K; Green JE; Ali IU; Smith LE; Senger DR
Am J Pathol; 2002 Jul; 161(1):35-41. PubMed ID: 12107087
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.
Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
Urology; 1998 Jan; 51(1):161-7. PubMed ID: 9457313
[TBL] [Abstract][Full Text] [Related]
17. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
18. Role of angiogenesis in the progression and treatment of prostate cancer.
Choy M; Rafii S
Cancer Invest; 2001; 19(2):181-91. PubMed ID: 11296622
[No Abstract] [Full Text] [Related]
19. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
Bostwick DG; Aquilina JW
J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
Rofstad EK; Halsør EF
Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
